Capricor Therapeutics Inc... (CAPR)
NASDAQ: CAPR
· Real-Time Price · USD
5.94
-0.34 (-5.41%)
At close: Sep 04, 2025, 3:59 PM
6.05
1.85%
Pre-market: Sep 05, 2025, 09:17 AM EDT
-5.41% (1D)
| Bid | 5.68 |
| Market Cap | 271.56M |
| Revenue (ttm) | 13.39M |
| Net Income (ttm) | -69.98M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -3.74 |
| Forward PE | -104.67 |
| Analyst | Buy |
| Ask | 6.3 |
| Volume | 1,946,338 |
| Avg. Volume (20D) | 2,500,693 |
| Open | 6.32 |
| Previous Close | 6.28 |
| Day's Range | 5.68 - 6.32 |
| 52-Week Range | 3.98 - 23.40 |
| Beta | 0.59 |
About CAPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CAPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CAPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Capricor Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+12.39%
Capricor Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
1 month ago
+21.36%
Shares of several biotechnology stocks are trading higher amid Vinay Prasad's departure as director of the FDA's Center for Biologics Evaluation and Research.
